Resistance Training as an Aid to Smoking Cessation Treatment
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Study Type
Study Type
Enrollment (Actual)
Enrollment
Phase
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
New York
-
New York, New York, United States, 10027
- Teachers College, Columbia University
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
Age 18 or older, smoke five or more cigarettes a day for at least the past 12 months
Exclusion Criteria:
Participating in any type of exercise for >60 minutes/week over the past 3 months, current smokeless tobacco use, participation in an ongoing effort to quit smoking, current or planned pregnancy, any serious medical condition that would make exercise unsafe
Study Plan
How is the study designed?
Design Details
- Primary Purpose: TREATMENT
- Allocation: RANDOMIZED
- Interventional Model: SINGLE_GROUP
- Masking: NONE
Number of Arms
Arms and Interventions
Participant Group / ArmParticipant Group / Arm |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
EXPERIMENTAL: Resistance training
Participants will attend two, 45-60-minute progressive, moderate intensity resistance training sessions per week for 12 weeks.
The program will maintain a format of a 5-minute warm-up, 35-50 minutes of resistance training and a 5-minute cool-down with flexibility and abdominal exercises.
|
|
|
ACTIVE_COMPARATOR: Health and Wellness
Participants in this group will be required to attend the exact same number of sessions as those in the Resistance Training group.
Each session will last approximately 45-60 minutes.
Sessions will include a practical component/demonstration, an informational video, and a handout on a pertinent healthy lifestyle topic for adults.
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Smoking cessation
Time Frame: Change from baseline to 3 months
|
Salivary cotinine-verified 7-day Point Prevalence Abstinence (7-day PPA) from nicotine (cigarette smoking).
|
Change from baseline to 3 months
|
Secondary Outcome Measures
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Cortisol
Time Frame: 3, 6, 12 months
|
3, 6, 12 months
|
|
|
Mood
Time Frame: 3, 6, 12 months
|
3, 6, 12 months
|
|
|
Cigarette cravings
Time Frame: 3, 6, 12 months
|
3, 6, 12 months
|
|
|
Abstinence self-efficacy
Time Frame: 3, 6, 12 months
|
3, 6, 12 months
|
|
|
Sleep
Time Frame: 3, 6, 12 months
|
3, 6, 12 months
|
|
|
Body composition
Time Frame: 3, 6, 12 months
|
3, 6, 12 months
|
|
|
Body weight
Time Frame: 3, 6, 12 months
|
3, 6, 12 months
|
|
|
Lung function
Time Frame: 3, 6, 12 months
|
3, 6, 12 months
|
|
|
Blood pressure
Time Frame: 3, 6, 12 months
|
3, 6, 12 months
|
|
|
Cholesterol profile
Time Frame: 3, 6, 12 months
|
3, 6, 12 months
|
|
|
Glycosylated hemoglobin
Time Frame: 3, 6, 12 months
|
3, 6, 12 months
|
|
|
Muscular strength
Time Frame: 3, 6, 12 months
|
3, 6, 12 months
|
|
|
Aerobic fitness
Time Frame: 3, 6, 12 months
|
Six-minute walk test
|
3, 6, 12 months
|
|
Smoking cessation
Time Frame: Change from baseline to 6 months
|
Salivary cotinine-verified 7-day Point Prevalence Abstinence (7-day PPA) from nicotine (cigarette smoking).
|
Change from baseline to 6 months
|
|
Smoking cessation
Time Frame: Change from baseline to 12 months
|
Salivary cotinine-verified 7-day Point Prevalence Abstinence (7-day PPA) from nicotine (cigarette smoking).
|
Change from baseline to 12 months
|
Collaborators and Investigators
Sponsor
Sponsor
Collaborators
Collaborators
Study record dates
Study Major Dates
Study Start
Study Start
Primary Completion (ACTUAL)
Primary Completion
Study Completion (ACTUAL)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (ESTIMATE)
First Posted
Study Record Updates
Last Update Posted (ACTUAL)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Keywords
Other Study ID Numbers
Other Study ID Numbers
- 1R01HL117345-01A1 (NIH)
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.